BioCentury
ARTICLE | Financial News

bluebird bio completes follow-on

June 29, 2015 7:00 AM UTC

bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date completed: 2015-06-23 Type: Follow-on Raised: $500 million Shares: 2.9 million Price: $170 Sha...